INS and type 2 diabetes mellitus: Type 2 diabetes mellitus (T2DM) accounts for approximately 85-95% of all cases of diabetes, which is a progressive hyperglycemic disease initially characterized by decreasing sensitivity of peripheral tissues to plasma insulin, accompanied by compensatory hyperinsulinemia, and a gradual failure of the pancreatic β-cells to maintain glucose homeostasis 1.